))
Navigating Cell & Gene Therapy: Cultivating Partnerships and Progress
Manage episode 490613025 series 3667451
Content provided by MEDVACON Life Sciences. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MEDVACON Life Sciences or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Welcome to Part 3 of Medvacon’s 4-part series entitled “Navigating Cell & Gene Therapy”, where Joe and Mike continue their visit with industry leader Ray Kaczmarek. In this episode, the 3 dive deep into the significance of disciplined development, strong supply chains, and well-cultivated partnerships within the cell and gene therapy space.
The conversation emphasizes the importance of selecting the right partners and managing those relationships effectively to ensure business success and compliance. Key topics include understanding both scientific and financial investments, the implications of bad contracts, and the critical role that quality and supply agreements play in maintaining smooth operations.
Contact MEDVACON:
- Message us at @MedvaconLifeSciences on LinkedIn
- Visit our website at www.medvacon.com/contact
- Email us at [email protected]
Thanks for listening! Don't forget to follow us @medvacon on all platforms for updates on blogs and podcasts!
Chapters
1. Introduction and Recap of Parts 1 and 2 (00:00:00)
2. The Business Case for Disciplined Development and Good Partnerships (00:01:25)
3. Supply Chain Management (00:09:54)
4. Quality Agreements and Their Significance (00:17:10)
5. Conclusion and Look Forward (00:26:38)
30 episodes
Share
